PLAY PODCASTS
Goldman Higher on Earnings; Apple Tariff Relieve; Pfizer Drug Pivot

Goldman Higher on Earnings; Apple Tariff Relieve; Pfizer Drug Pivot

Stock Movers

April 14, 20253m 55s

Audio is streamed directly from the publisher (podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

On this episode of Stock Movers:
- Goldman Sachs (GS) shares are higher after reporting earnings. The big bank approved a $40 billion share buyback program and its 1Q equities trading revenue beat estimates.
- Apple (AAPL) is also higher with news of tech tariff exemptions. Needham analyst Laura Martin is also reiterating her Apple Buy position in addition to the news, maintaining her $225 price target.
- Pfizer (PFE) is down today as it plans to abandon its obesity pill, danuglipron, due to a potentially drug-related liver injury in a clinical trial patient. The company will instead invest in earlier-stage obesity treatments, a setback in its efforts to compete with Novo Nordisk and Eli Lilly in the weight-loss market.
- Intel (INTC) is soaring this morning as many chip-exposed companies are rising on news of a pause in US tariffs on chips and tech. Intel is also nearing an agreement to sell a stake in its programmable chips unit, Altera, to Silver Lake Management.

See omnystudio.com/listener for privacy information.